Gyneco-Obstetric Ultrasound Systems Market Report 2025

This Gyneco-Obstetric Ultrasound Systems market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The gyneco-obstetric ultrasound systems market size has grown strongly in recent years. It will grow from $2.77 billion in 2024 to $2.99 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be attributed to a greater focus on maternal and fetal health, the rising prevalence of gynecological conditions, expanded healthcare infrastructure in developed regions, the introduction of Doppler ultrasound, initiatives by governments and NGOs, improved imaging standards, awareness and education campaigns, a decline in the cost of basic ultrasound systems, and increased demand in developing economies.

The gyneco-obstetric ultrasound systems market size is expected to see strong growth in the next few years. It will grow to $3.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The expected growth in the forecast period is driven by the rising adoption of portable and handheld ultrasound devices, an increase in the prevalence of gynecological conditions, greater awareness of maternal health, growing healthcare investments in emerging markets, and favorable regulatory and reimbursement support. Key trends in the forecast period include the wider use of portable and handheld ultrasound devices, expanded applications, growing maternal health awareness, increased healthcare investments in emerging markets, a rise in demand for personalized and preventive care, and continued regulatory and reimbursement support.

The rising prevalence of gynecological disorders is expected to drive the growth of the gyneco-obstetric ultrasound systems market. These disorders affect the female reproductive system, including the uterus, ovaries, cervix, and vagina. Contributing factors to the increase in these conditions include lifestyle changes, obesity, environmental influences, delayed childbearing, and stress-related mental health issues. Gyneco-obstetric ultrasound systems assist in diagnosing and monitoring gynecological disorders by providing detailed images of reproductive organs, which helps in early detection and planning for treatment. For example, in June 2024, the American Cancer Society, a US-based non-profit organization focused on cancer prevention, projected that approximately 13,820 new cases of invasive cervical cancer would be diagnosed in 2024, with an estimated 4,360 women expected to die from cervical cancer that year. Thus, the rising number of gynecological disorders is driving the demand for gyneco-obstetric ultrasound systems.

Leading companies in the gyneco-obstetric ultrasound systems market are focusing on integrating artificial intelligence (AI) and machine learning (ML) into their ultrasound systems to automate image analysis. These technologies improve the accuracy of abnormality detection, enhance workflow efficiency, and provide real-time insights, helping clinicians make better decisions. For instance, in February 2023, Samsung Healthcare, a South Korea-based medical equipment manufacturer, introduced the HERA W10 Elite, an ultrasound system for obstetrics and gynecology. This system includes advanced IT integration to improve diagnostic accuracy and efficiency. It features Advanced MV-Flow for detailed 2D and 3D imaging of microcirculation, HeartAssist AI for automated fetal heart measurements, and the forthcoming Biometry Assist for one-click fetal growth assessment. Its OLED display and innovative transducers set a new benchmark for women’s health imaging.

In May 2024, Samsung Medison Co. Ltd., a South Korea-based manufacturer of diagnostic ultrasound devices, acquired Sonio, a France-based company that provides cloud-based OB-GYN ultrasound software. The acquisition enhances Samsung's ultrasound systems with Sonio Detect’s advanced AI capabilities, improving imaging precision and efficiency in prenatal care.

Major players in the gyneco-obstetric ultrasound systems market are Samsung Medison Co. Ltd., Hitachi Ltd, Canon Medical Systems Corporation, Siemens Healthcare Private Limited, Toshiba Medical Systems Corporation, Fujifilm Holdings Corporation, Koninklijke Philips NV, GE Healthcare, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Mindray Medical International Limited, Esaote SPA, SonoScape Medical Corp, Chison Medical Imaging Co Ltd, Promed Group Co Ltd, Shenzhen Biocare Bio-Medical Equipment Co Ltd, SuperSonic Imagine, MedGyn Products Inc, Teratech Corporation, Dramiński S.A., Caresono Technology Co Ltd, Xuzhou Kejian Hi-tech Co Ltd, SIFSOF LLC, ContextVision AB.

North America was the largest region in the gyneco-obstetric ultrasound systems market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gyneco-obstetric ultrasound systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the gyneco-obstetric ultrasound systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Gyneco-obstetric ultrasound systems are advanced imaging tools used in gynecology and obstetrics to examine the female reproductive system and monitor pregnancy. These systems generate detailed internal images, allowing for non-invasive assessments and diagnoses. They operate by using sound waves to create images of the body’s internal structures relevant to gynecological and obstetrical care.

The primary types of gyneco-obstetric ultrasound systems are 2D, 3D/4D, and Doppler ultrasound. 2D ultrasound is a conventional imaging method that produces flat, two-dimensional images of internal structures and is commonly used to track fetal growth and evaluate reproductive organs. These systems are divided into portable and on-platform devices, with their main applications in obstetrics and gynecology. The primary users of these ultrasound systems include hospitals, diagnostic facilities, and gynecology clinics, providing vital care for women’s health.

The gyneco-obstetric ultrasound systems market research report is one of a series of new reports that provides gyneco-obstetric ultrasound systems market statistics, including gyneco-obstetric ultrasound systems industry global market size, regional shares, competitors with a gyneco-obstetric ultrasound systems market share, detailed gyneco-obstetric ultrasound systems market segments, market trends and opportunities, and any further data you may need to thrive in the gyneco-obstetric ultrasound systems industry. This gyneco-obstetric ultrasound systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gyneco-obstetric ultrasound systems market consists of sales of specialized ultrasound devices and doppler imaging systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.